Concepedia

Walter E. DeWolf

WE

49

Publications

3.2K

Citations

32

H-Index

1979

Active since

Affiliations

Array BioPharma (United States)(Current)

New Frontier

GlaxoSmithKline (United States)

Amgen (United States)

Temple University

Walter E. DeWolf is an author at Array BioPharma (United States) specializing in pharmacology, medicine, and biochemistry.

Top concepts

Publications per year

1979–2019

49

Publications

49

A Next-Generation TRK Kinase Inhibitor Overcomes Acquired Resistance to Prior TRK Kinase Inhibition in Patients with TRK Fusion–Positive Solid Tumors

Alexander Drilon, Ramamoorthy Nagasubramanian, James F. Blake et al. · Cancer Discovery · 2017 · 419 citations · Full text

Potent and Selective Nonpeptide Inhibitors of Caspases 3 and 7 Inhibit Apoptosis and Maintain Cell Functionality

Dennis Lee, Scott A. Long, Jerry L. Adams et al. · Journal of Biological Chemistry · 2000 · 232 citations · Full text

Potent and Selective Nonpeptide Inhibitors of Caspases 3 and 7

Dennis Lee, Scott A. Long, Jeffrey H. Murray et al. · Journal of Medicinal Chemistry · 2001 · 164 citations · Full text

, , +19

Discovery of a Novel and Potent Class of FabI-Directed Antibacterial Agents

David Payne, William H. Miller, Valerie Berry et al. · Antimicrobial Agents and Chemotherapy · 2002 · 163 citations · Full text

Indole Naphthyridinones as Inhibitors of Bacterial Enoyl-ACP Reductases FabI and FabK

Mark A. Seefeld, William H. Miller, Kenneth A. Newlander et al. · Journal of Medicinal Chemistry · 2003 · 161 citations · Full text

, , +20

Rows per page

1–5 of 49